Elanco named Diamond Sponsor of London Vet Show for 2026, showcasing latest innovations in canine and feline care

Bringing a little Zen to London Vet Show

Amid the buzz of one of the biggest events in the veterinary calendar, Elanco will be creating its own Zen-inspired space… and it should be hard to miss!

A huge blossom tree will take centre stage on Stand L20, creating a relaxed setting where delegates can step away from the crowds, meet the Elanco team, and talk about all things canine atopic dermatitis. A Zenrelia-sponsored seating area in front of the stand will offer another place to take the weight off your paws during a busy day at the show.

Zenrelia returns to LVS following its debut in 2025 and a significant milestone for the treatment, with more than two million dogs now treated worldwide since launch*.

New for 2026: a bigger spotlight on feline care

For 2026, Elanco is expanding its presence with a dedicated feline area, giving delegates the opportunity to discover Varenzin and Eluracat, two of the latest innovations in Elanco’s feline portfolio. Veterinary professionals will be able to learn more about both treatments and speak directly with the Elanco team about their use in feline patients.

Varenzin offers a first-of-its-kind, once-daily oral treatment for managing anaemia associated with chronic kidney disease (CKD) in cats, while Eluracat is a once-daily oral solution designed to support cats experiencing poor appetite or unintended weight loss associated with chronic medical conditions. Together, they represent two of Elanco’s latest innovations supporting the management of common challenges in cats living with chronic disease.

The conversation won’t stop at Stand L20. Elanco will also host three symposium sessions across the two days of London Vet Show, with two tackling the challenges of itchy dogs and canine dermatology and one putting feline care centre stage.

Matt Frost, General Manager UK & Ireland at Elanco Animal Health, says: “London Vet Show is always a great opportunity for us to meet veterinary professionals face-to-face, hear about the challenges they are seeing in practice and discuss the latest thinking and innovation.

“We’re particularly excited this year to welcome delegates back to the world of Zenrelia, which returns to LVS having reached the milestone of more than two million dogs treated worldwide since launch. We’re also shining a bigger spotlight on feline care following the UK launches of Varenzin and Eluracat this year.

“Whether you’re here to hear from our speakers, talk to the team or simply take a moment under the blossom tree, we look forward to welcoming you to Stand L20.”

London Vet Show takes place at ExCeL London on 19–20 November 2026. Visit the Elanco Animal Health at Stand L20.

* Elanco Global Sales Data March 2026

Zenrelia™ film coated tablets contain ilunocitinib. Legal category POM-V in UK, POM in

IE. Eluracat oral solution for cats contains capromorelin. Legal category POM-V in UK, POM in IE. Varenzin Oral Suspension for Cats contains molidustat sodium. Legal category POM-V in UK, POM in IE. For further information call Elanco Animal Health on +44(0)1256 353131 or write to:

Elanco UK AH Limited, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27

9XA, United Kingdom. For further information, consult the product SPC. Zenrelia, Eluracat, Varenzin, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

©2026 Elanco or its affiliates PM-UK-26-0325. Date of preparation 10/26

Advice should be sought from the medicine prescriber prior to use. Prescription

decisions are for the person issuing the prescription alone.

Use medicines responsibly www.noah.co.uk/responsible. www.apha.ie